SKI Market

A+| A| A-|

Indian Indices

Sensex

77,763.91 261.79
( 0.34%)

Global Indices

Nasdaq

52,909.39 583.15
(1.11%)

Dow Jones

7,503.05 -1.18
(-0.02%)

Hang Seng

69,733.68 1,000.53
(1.46%)

Nikkei 225

10,664.80 186.46
(1.78%)

Forex

USD-INR

94.99 0.39
(0.42%)

EUR-INR

108.21 0.30
(0.28%)

GBP-INR

125.93 0.66
(0.53%)

JPY-INR

0.58 0.00
(0.27%)

YOU ARE HERE :
HOME
Markets
Equity
Profit and Loss

EQUITY - MARKET SCREENER

Zim Laboratories Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

541400

INE518E01015

53.0292332

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

ZIMLAB

150.12

659.19

EPS(TTM)

Face Value()

Div & Yield %

0.82

Particulars(INCOME)	Mar 2026 ( Cr)	Mar 2025 ( Cr)	Mar 2024 ( Cr)	Mar 2023 ( Cr)	Mar 2022 ( Cr)	Mar 2021 ( Cr)
Sales Turnover	370.48	375.64	365.47	396.53	329.49	303.63
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	370.48	375.64	365.47	396.53	329.49	303.63
Other Income	11.39	5.62	4.69	6.43	4.51	2.45
Stock Adjustments	6.14	-1.27	14.05	-16.46	9.67	1.11
Total Income	388.01	379.99	384.21	386.50	343.67	307.19
EXPENDITURE :
Raw Materials	170.66	166.58	185.49	182.37	170.02	159.74
Power & Fuel Cost	18.17	17.39	13.47	11.09	9.14	7.04
Employee Cost	60.10	56.41	50.81	46.47	38.63	34.48
Other Manufacturing Expenses	38.46	32.14	31.97	27.30	23.76	19.02
Selling & Administrative Expenses	54.47	52.04	51.66	55.69	54.44	43.70
Miscellaneous Expenses	5.19	6.54	6.03	5.95	5.24	9.12
Less : Pre-operative Expenses Capitalised	0.00	0.00	0.00	0.00	0.00	0.00
Total Expenditure	347.04	331.10	339.42	328.87	301.23	273.11
Operating Profit	40.97	48.89	44.79	57.63	42.44	34.08
Interest	13.20	11.39	6.92	5.58	8.31	10.89
Gross Profit	27.77	37.50	37.87	52.05	34.13	23.19
Depreciation	19.37	19.89	14.83	16.13	14.84	14.61
Profit Before Tax	8.40	17.61	23.04	35.92	19.29	8.58
Tax	3.28	4.45	0.83	6.28	3.40	0.02
Fringe Benefit tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	-0.84	1.42	5.45	4.63	2.88	2.95
Reported Net Profit	5.97	11.74	16.76	25.01	13.01	5.62
Extraordinary Items	1.56	0.08	-0.01	0.00	0.00	-3.39
Adjusted Net Profit	4.41	11.66	16.77	25.01	13.01	9.01
Adjustment below Net Profit	0.00	0.00	0.00	0.00	0.00	0.00
P & L Balance brought forward	163.94	152.73	136.36	111.81	98.76	93.52
Statutory Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
Appropriations	0.10	0.54	0.38	0.46	-0.05	0.39
P & L Balance carried down	169.81	163.94	152.73	136.36	111.81	98.76
Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Preference Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Equity Dividend %	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Per Share(Rs)	0.00	0.00	0.00	0.00	0.00	0.00
Earnings Per Share-Unit Curr	1.11	2.41	3.44	5.13	8.01	3.46
Earnings Per Share(Adj)-Unit Curr	1.11	2.41	3.44	5.13	2.67	1.15
Book Value-Unit Curr	53.07	49.90	47.60	39.85	104.73	96.69
Book Value(Adj)-Unit Curr	53.07	49.90	47.60	39.85	34.91	32.23

77,763.91 261.79 ( 0.34%)

52,909.39 583.15 (1.11%)

7,503.05 -1.18 (-0.02%)

69,733.68 1,000.53 (1.46%)

10,664.80 186.46 (1.78%)

94.99 0.39 (0.42%)

108.21 0.30 (0.28%)

125.93 0.66 (0.53%)

0.58 0.00 (0.27%)